Literature DB >> 32246469

Colorectal cancer treated by resection and extended lymphadenectomy: patterns of spread in left- and right-sided tumours.

K Kataoka1, N Beppu1, M Shiozawa2, M Ikeda1, N Tomita1, H Kobayashi3, K Sugihara4, W Ceelen5,6.   

Abstract

BACKGROUND: Whether tumour side affects the anatomical extent and distribution of lymph node metastasis in colon cancer is unknown. The impact of tumour side on the anatomical pattern of lymphatic spread in colon cancer was assessed.
METHODS: Patients with stage III colon cancer from a Japanese multi-institutional database who underwent extensive (D3) lymphadenectomy, which is similar in concept to complete mesocolic excision with central venous ligation, were divided into groups with right- and left-sided tumours. Based on location, mesenteric lymph nodes were categorized as paracolic (L1), intermediate (L2) or central (L3). The Kaplan-Meier method was used to evaluate disease-free survival (DFS) and overall survival (OS), and multivariable Cox models were used to evaluate the association between anatomical lymph node level, metastatic pattern and outcome.
RESULTS: A total of 4034 patients with stage III colon cancer (right 1618, left 2416) were included. Unadjusted OS was worse in patients with right colon cancer (hazard ratio 1·23, 95 per cent c.i. 1·08 to 1·40; P = 0·002), but DFS was similar. Right-sided tumours more frequently invaded L3 nodes than left-sided lesions (8·5 versus 3·7 per cent; P < 0·001). The proportion of patients with a skipped pattern of lymphatic spread was higher in right than in left colon cancer (13·7 versus 9·0 per cent; P < 0·001). In multivariable analysis, invasion of L3 nodes was associated with worse OS in left but not in right colon cancer. The presence of skipped metastasis was associated with worse DFS in left, but not right, colon cancer.
CONCLUSION: There are significant differences in the pattern of lymph node invasion between right- and left-sided stage III colon cancer, and in their prognostic significance, suggesting that tumour side may dictate the operative approach.
© 2020 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Year:  2020        PMID: 32246469     DOI: 10.1002/bjs.11517

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

Review 1.  Definition and reporting of lymphadenectomy and complete mesocolic excision for radical right colectomy: a systematic review.

Authors:  Giuseppe S Sica; Danilo Vinci; Leandro Siragusa; Bruno Sensi; Andrea M Guida; Vittoria Bellato; Álvaro García-Granero; Gianluca Pellino
Journal:  Surg Endosc       Date:  2022-09-12       Impact factor: 3.453

2.  The impact of molecular profile on the lymphatic spread pattern in stage III colon cancer.

Authors:  Jihyung Song; Kozo Kataoka; Takeshi Yamada; Manabu Shiozawa; Tomohiro Sonoyama; Naohito Beppu; Koji Ueda; Sho Kuriyama; Akiyoshi Kanazawa; Masataka Ikeda; Wim Ceelen
Journal:  Cancer Sci       Date:  2021-02-18       Impact factor: 6.716

3.  Comparing 5-Year Survival Rates Before and After Re-stratification of Stage I-III Right-Sided Colon Cancer Patients by Establishing the Presence/Absence of Occult Tumor Cells and Lymph Node Metastases in the Different Levels of Surgical Dissection.

Authors:  G S Banipal; B V Stimec; S N Andersen; A E Faerden; B Edwin; J Baral; J M Nesgaard; J Šaltytė Benth; D Ignjatovic
Journal:  J Gastrointest Surg       Date:  2022-08-29       Impact factor: 3.267

4.  Modified complete mesocolic excision with central vascular ligation by the squeezing approach in laparoscopic right colectomy.

Authors:  Nobuki Ichikawa; Shigenori Homma; Tadashi Yoshida; Shin Emoto; Ken Imaizumi; Yoichi Miyaoka; Hiroki Matsui; Akinobu Taketomi
Journal:  Langenbecks Arch Surg       Date:  2021-07-13       Impact factor: 2.895

Review 5.  Right hemicolectomy with complete mesocolic excision is safe, leads to an increased lymph node yield and to increased survival: results of a systematic review and meta-analysis.

Authors:  G Anania; R J Davies; F Bagolini; N Vettoretto; J Randolph; R Cirocchi; A Donini
Journal:  Tech Coloproctol       Date:  2021-06-12       Impact factor: 3.781

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.